{"DataElement":{"publicId":"3623374","version":"1","preferredName":"Residual Primary Tumor Post Surgical Procedure Category","preferredDefinition":"Value to represent the number of residual primary tumors present.","longName":"3623366v1.0:3623368v1.0","context":"BOLD","contextVersion":"1","DataElementConcept":{"publicId":"3623366","version":"1","preferredName":"Residual Neoplasm Post Surgical Procedure Assessment","preferredDefinition":"Remaining or left behind._A benign or malignant tissue growth resulting from uncontrolled cell proliferation.  Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia.  Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.)._Happening at a time subsequent to a reference time; later in time or order._A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery._The final result of a determination of the value, significance, or extent of.","longName":"2503791v1.0:3623364v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2503791","version":"1","preferredName":"Residual Neoplasm","preferredDefinition":"Remaining or left behind.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C37895:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Residual","conceptCode":"C37895","definition":"Remaining or left behind.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1A85D824-42F4-4C72-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-08-08","modifiedBy":"ONEDATA","dateModified":"2006-08-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3623364","version":"1","preferredName":"Post Surgical Procedure Assessment","preferredDefinition":"Happening at a time subsequent to a reference time; later in time or order.:A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.:The final result of a determination of the value, significance, or extent of.","longName":"C38008:C15329:C25367","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Post","conceptCode":"C38008","definition":"Happening at a time subsequent to a reference time; later in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Surgical Procedure","conceptCode":"C15329","definition":"A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assessment","conceptCode":"C25367","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CCB9CF63-FDBF-864D-E040-BB89AD434A34","latestVersionIndicator":"Yes","beginDate":"2012-10-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-10-23","modifiedBy":"ONEDATA","dateModified":"2012-10-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008574","version":"1","preferredName":"Surgical Margin Measurements","preferredDefinition":"any measurements of a patient's surgical margins.","longName":"SURG_MARG_MSRMTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB880E47-7AFF-254C-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-04-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-04-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CCB9CF63-FDD0-864D-E040-BB89AD434A34","latestVersionIndicator":"Yes","beginDate":"2012-10-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-10-23","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3623368","version":"1","preferredName":"Residual Disease Primary Tumor Category","preferredDefinition":"Cancer cells that remain after attempts to remove the cancer have been made._The original tumor._Category; used informally to mean a class of things.","longName":"3623368v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":">3","valueDescription":"More than Three Tumors","ValueMeaning":{"publicId":"3623369","version":"1","preferredName":"More than Three Tumors","longName":"3623369","preferredDefinition":"A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.: A natural number greater than 2 and less than 4 and the quantity that it denotes: the sum of two and one.: A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Greater Than","conceptCode":"C61584","definition":"A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Three","conceptCode":"C66834","definition":"A natural number greater than 2 and less than 4 and the quantity that it denotes: the sum of two and one.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CCB9CF63-FE11-864D-E040-BB89AD434A34","latestVersionIndicator":"Yes","beginDate":"2012-10-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-10-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CCB9CF63-FE2A-864D-E040-BB89AD434A34","beginDate":"2012-10-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-10-23","modifiedBy":"ONEDATA","dateModified":"2012-10-23","deletedIndicator":"No"},{"value":"3","valueDescription":"Three Tumors","ValueMeaning":{"publicId":"3623370","version":"1","preferredName":"Three Tumors","longName":"3623370","preferredDefinition":"A natural number greater than 2 and less than 4 and the quantity that it denotes: the sum of two and one.: A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Three","conceptCode":"C66834","definition":"A natural number greater than 2 and less than 4 and the quantity that it denotes: the sum of two and one.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CCB9CF63-FE37-864D-E040-BB89AD434A34","latestVersionIndicator":"Yes","beginDate":"2012-10-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-10-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CCB9CF63-FE50-864D-E040-BB89AD434A34","beginDate":"2012-10-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-10-23","modifiedBy":"ONEDATA","dateModified":"2012-10-23","deletedIndicator":"No"},{"value":"2","valueDescription":"Two Tumors","ValueMeaning":{"publicId":"3623371","version":"1","preferredName":"Two Tumors","longName":"3623371","preferredDefinition":"A natural number greater than 1 and less than 3 and the quantity that it denotes: the sum of one and one.: A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Two","conceptCode":"C66833","definition":"A natural number greater than 1 and less than 3 and the quantity that it denotes: the sum of one and one.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CCB9CF63-FE5D-864D-E040-BB89AD434A34","latestVersionIndicator":"Yes","beginDate":"2012-10-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-10-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CCB9CF63-FE76-864D-E040-BB89AD434A34","beginDate":"2012-10-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-10-23","modifiedBy":"ONEDATA","dateModified":"2012-10-23","deletedIndicator":"No"},{"value":"1","valueDescription":"One Tumor","ValueMeaning":{"publicId":"3623372","version":"1","preferredName":"One Tumor","longName":"3623372","preferredDefinition":"The smallest natural number and quantity it denotes: a single entity, unit, or object.: A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"One","conceptCode":"C66832","definition":"The smallest natural number and quantity it denotes: a single entity, unit, or object.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CCB9CF63-FE83-864D-E040-BB89AD434A34","latestVersionIndicator":"Yes","beginDate":"2012-10-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-10-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CCB9CF63-FE9C-864D-E040-BB89AD434A34","beginDate":"2012-10-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-10-23","modifiedBy":"ONEDATA","dateModified":"2012-10-23","deletedIndicator":"No"},{"value":"0","valueDescription":"No Tumors","ValueMeaning":{"publicId":"3623373","version":"1","preferredName":"No Tumors","longName":"3623373","preferredDefinition":"A mathematical element that when added to another number yields the same number; the cardinal number meaning one less than one.: A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Zero","conceptCode":"C70430","definition":"A mathematical element that when added to another number yields the same number; the cardinal number meaning one less than one.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CCB9CF63-FEA9-864D-E040-BB89AD434A34","latestVersionIndicator":"Yes","beginDate":"2012-10-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-10-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CCB9CF63-FEC2-864D-E040-BB89AD434A34","beginDate":"2012-10-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-10-23","modifiedBy":"ONEDATA","dateModified":"2012-10-23","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3623367","version":"1","preferredName":"Residual Disease Primary Neoplasm Category","preferredDefinition":"Cancer cells that remain after attempts to remove the cancer have been made.:The original tumor.:Category; used informally to mean a class of things.","longName":"C4809:C8509:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Residual Disease","conceptCode":"C4809","definition":"Tumor cells that remain in the body following cancer treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Primary Neoplasm","conceptCode":"C8509","definition":"A tumor at the original site of origin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CCB9CF63-FDE7-864D-E040-BB89AD434A34","latestVersionIndicator":"Yes","beginDate":"2012-10-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-10-23","modifiedBy":"ONEDATA","dateModified":"2012-10-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CCB9CF63-FDF8-864D-E040-BB89AD434A34","latestVersionIndicator":"Yes","beginDate":"2012-10-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-10-23","modifiedBy":"REEVESD","dateModified":"2012-10-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3461586","version":"1","longName":"BOLD:Breast Oncology Local Disease","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461587","version":"1","longName":"Preoperative Elements","context":"NCIP"}]},{"publicId":"3886755","version":"1","longName":"Preoperative Elements","context":"BOLD","ClassificationSchemeItems":[{"publicId":"3902140","version":"1","longName":"Preoperative","context":"BOLD"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Number of residual primary tu","type":"Preferred Question Text","description":"Number of residual primary tumors","url":null,"context":"NCIP"}],"origin":"BOLD:Breast Oncology Local Disease Initiative","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CCB9CF63-FEEB-864D-E040-BB89AD434A34","latestVersionIndicator":"Yes","beginDate":"2012-10-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-10-23","modifiedBy":"REEVESD","dateModified":"2016-09-06","changeDescription":"Curated to support Breast Oncology Local Disease (BOLD) Initiative","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}